Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
yiqi huatan quyu
- Development stage
- Unknown
- Lead developer
- First Affiliated Hospital of Anhui University of Chinese Medicine
- Administration
- Oral
01
Overview
Yiqi Huatan Quyu is a Traditional Chinese Medicine (TCM) formula developed by the First Affiliated Hospital of Anhui University of Chinese Medicine for the treatment of chronic obstructive pulmonary disease (COPD). The formula is based on the therapeutic principle of supplementing Qi, resolving phlegm, and removing blood stasis, which targets the core pathological mechanisms of COPD according to TCM theory. It typically consists of herbal components such as Astragalus membranaceus, Salvia miltiorrhiza, Pinellia ternata, and Fritillaria thunbergii. Research indicates that the formula exerts anti-inflammatory effects by reducing the expression of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-8 (IL-8). Additionally, it helps regulate the protease-antiprotease balance by modulating matrix metalloproteinase-9 (MMP-9) levels. Clinical trials have demonstrated its efficacy in improving lung function, reducing the frequency of acute exacerbations, and enhancing the quality of life for patients with stable COPD.
- Brand names
- Yiqi Huatan Quyu Formula
- Other names
- Yiqi Huatan Quyu DecoctionYiqi Huatan Quyu GranulesYiqi Huatan Quyu FormulaYiqi Huatan Quyu Fang
02
Targets
IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)MMP9 (Matrix metalloproteinase-9)TNFA (Tumor necrosis factor alpha (soluble))IL8 (C-X-C Motif Chemokine Ligand 8)
Beyond the preview
Go deeper on yiqi huatan quyu.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on yiqi huatan quyu.